TYKVART, Jan, Václav NAVRÁTIL, Michael KUGLER, Pavel ŠÁCHA, Jiří SCHIMER, Anna HLAVÁČKOVÁ, Lukáš TENORA, Jitka ZEMANOVÁ, Jitka DEJMEK, Vlastimil KRÁL, Milan POTÁČEK, Pavel MAJER, Ullrich JAHN, Jiří BRYNDA, Pavlína ŘEZÁČOVÁ a Jan KONVALINKA. Identification of Novel Carbonic Anhydrase IX Inhibitors Using High-Throughput Screening of Pooled Compound Libraries by DNA-Linked Inhibitor Antibody Assay (DIANA). SLAS Discovery. SAGE Publications Inc, 2020, roč. 25, č. 9, s. 1026-1037. ISSN 2472-5552. Dostupné z: https://dx.doi.org/10.1177/2472555220918836.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Identification of Novel Carbonic Anhydrase IX Inhibitors Using High-Throughput Screening of Pooled Compound Libraries by DNA-Linked Inhibitor Antibody Assay (DIANA)
Autoři TYKVART, Jan (203 Česká republika, garant), Václav NAVRÁTIL (203 Česká republika), Michael KUGLER (203 Česká republika), Pavel ŠÁCHA (203 Česká republika), Jiří SCHIMER (203 Česká republika), Anna HLAVÁČKOVÁ (203 Česká republika), Lukáš TENORA (203 Česká republika, domácí), Jitka ZEMANOVÁ, Jitka DEJMEK, Vlastimil KRÁL, Milan POTÁČEK (203 Česká republika, domácí), Pavel MAJER, Ullrich JAHN, Jiří BRYNDA, Pavlína ŘEZÁČOVÁ a Jan KONVALINKA.
Vydání SLAS Discovery, SAGE Publications Inc, 2020, 2472-5552.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 10608 Biochemistry and molecular biology
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 2.918
Kód RIV RIV/00216224:14310/20:00116956
Organizační jednotka Přírodovědecká fakulta
Doi http://dx.doi.org/10.1177/2472555220918836
UT WoS 000535984500001
Klíčová slova anglicky high-throughput screening; carbonic anhydrase IX; drug discovery; DNA-linked inhibitor antibody assay
Štítky rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Marie Šípková, DiS., učo 437722. Změněno: 27. 11. 2020 09:29.
Anotace
The DNA-linked inhibitor antibody assay (DIANA) has been recently validated for ultrasensitive enzyme detection and for quantitative evaluation of enzyme inhibitor potency. Here we present its adaptation for high-throughput screening of human carbonic anhydrase IX (CAIX), a promising drug and diagnostic target. We tested DIANA's performance by screening a unique compound collection of 2816 compounds consisting of lead-like small molecules synthesized at the Institute of Organic Chemistry and Biochemistry (IOCB) Prague (“IOCB library”). Additionally, to test the robustness of the assay and its potential for upscaling, we screened a pooled version of the IOCB library. The results from the pooled screening were in agreement with the initial nonpooled screen with no lost hits and no false positives, which shows DIANA’s potential to screen more than 100,000 compounds per day.All DIANA screens showed a high signal-to-noise ratio with a Z factor of >0.89. The DIANA screen identified 13 compounds with Ki values equal to or better than 10 uM. All retested hits were active also in an orthogonal enzymatic assay showing zero false positives. However, further biophysical validation of identified hits revealed that the inhibition activity of several hits was caused by a single highly potent CAIX inhibitor, being present as a minor impurity. This finding eventually led us to the identification of three novel CAIX inhibitors from the screen. We confirmed the validity of these compounds by elucidating their mode of binding into the CAIX active site by x-ray crystallography.
VytisknoutZobrazeno: 12. 7. 2024 12:57